Blue Trust Inc. Increases Stock Position in Genpact Limited (NYSE:G)

Blue Trust Inc. grew its position in Genpact Limited (NYSE:G) by 8.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,531 shares of the business services provider’s stock after buying an additional 441 shares during the quarter. Blue Trust Inc.’s holdings in Genpact were worth $217,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently bought and sold shares of the company. JPMorgan Chase & Co. increased its holdings in shares of Genpact by 192.8% in the 3rd quarter. JPMorgan Chase & Co. now owns 3,129,341 shares of the business services provider’s stock valued at $122,701,000 after acquiring an additional 2,060,595 shares during the period. Los Angeles Capital Management LLC purchased a new stake in shares of Genpact during the third quarter worth approximately $19,779,000. Tandem Investment Advisors Inc. acquired a new stake in shares of Genpact during the third quarter worth $17,025,000. Geode Capital Management LLC lifted its holdings in shares of Genpact by 12.6% during the third quarter. Geode Capital Management LLC now owns 3,691,406 shares of the business services provider’s stock worth $148,142,000 after purchasing an additional 413,646 shares during the period. Finally, Franklin Resources Inc. grew its position in Genpact by 6.5% in the 3rd quarter. Franklin Resources Inc. now owns 4,148,185 shares of the business services provider’s stock valued at $162,318,000 after buying an additional 252,674 shares during the last quarter. 96.03% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Genpact

In related news, SVP Piyush Mehta sold 12,000 shares of Genpact stock in a transaction dated Friday, January 10th. The stock was sold at an average price of $42.83, for a total value of $513,960.00. Following the sale, the senior vice president now owns 151,182 shares of the company’s stock, valued at approximately $6,475,125.06. The trade was a 7.35 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Balkrishan Kalra sold 9,000 shares of the business’s stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $46.40, for a total value of $417,600.00. Following the transaction, the chief executive officer now directly owns 267,404 shares in the company, valued at $12,407,545.60. This trade represents a 3.26 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 35,058 shares of company stock valued at $1,558,675. Corporate insiders own 2.80% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have weighed in on G shares. Needham & Company LLC increased their target price on shares of Genpact from $42.00 to $55.00 and gave the company a “buy” rating in a report on Monday, November 11th. Jefferies Financial Group upgraded Genpact from a “hold” rating to a “buy” rating and upped their price target for the stock from $44.00 to $55.00 in a report on Tuesday, January 21st. Robert W. Baird lifted their price objective on Genpact from $44.00 to $48.00 and gave the stock a “neutral” rating in a report on Friday, November 8th. Finally, TD Cowen raised their price target on Genpact from $40.00 to $45.00 and gave the company a “hold” rating in a research report on Friday, November 8th. Six analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Genpact presently has a consensus rating of “Hold” and a consensus target price of $44.50.

Genpact Price Performance

Genpact stock opened at $48.94 on Tuesday. The business has a 50 day simple moving average of $44.75 and a 200 day simple moving average of $40.92. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.85 and a quick ratio of 1.85. The company has a market capitalization of $8.63 billion, a PE ratio of 13.44, a price-to-earnings-growth ratio of 1.61 and a beta of 1.20. Genpact Limited has a one year low of $30.23 and a one year high of $49.15.

Genpact (NYSE:G) last released its quarterly earnings results on Thursday, November 7th. The business services provider reported $0.75 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.71 by $0.04. Genpact had a return on equity of 21.85% and a net margin of 14.22%. The business had revenue of $1.21 billion during the quarter, compared to analysts’ expectations of $1.19 billion. During the same period in the previous year, the business posted $0.67 earnings per share. On average, sell-side analysts forecast that Genpact Limited will post 2.94 EPS for the current fiscal year.

Genpact Company Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.